16.12.2014
- Bayer has failed in the last round of its effort to block the sale of a cheap generic version of its cancer drug Nexavar in India. In a Dec. 12 decision, the country's Supreme...
11.12.2014
- Merck & Co has said it will proceed with its planned $8.4 billion acquisition of Cubist Pharmaceuticals in the first quarter of 2015 and still expects the deal to boost its long...
12.08.2014
- US generic drugmaker Mylan has shaved the top end of its full-year revenue and earnings forecasts slightly, citing delays in approval from the US Food and Drug Administration for...
15.07.2014
- Teva Pharmaceutical Industries board is to appoint vice-chairman Amir Elstein as its new chairman, activist shareholder Benny Landa has said. "I was informed by Moshe Many, Amir...
15.07.2014
- Generic drugmaker Mylan said it plans to acquire Abbott Laboratories' branded specialty and generics business in developed markets outside the US for $5.3 billion. Both companies...
30.06.2014
- The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...
27.05.2014
- In a move widely expected, Pfizer abandoned its attempt to buy AstraZeneca for nearly £70 billion ($118 billion) on May 26 as a final deadline mandated by British law approached...
16.05.2014
- Shortly before expiration of the patent on the multiple sclerosis treatment Copaxone, a US district court has dismissed a case by Teva Pharmaceutical Industries, subsidiary of the...
